{Reference Type}: Journal Article
{Title}: Optimising the oral midazolam dose for premedication in people with intellectual disabilities and/or autism spectrum disorder.
{Author}: Higuchi H;Miyake K;Miyake S;Fujimoto M;Nishioka Y;Maeda S;Miyawaki T;
{Journal}: J Appl Res Intellect Disabil
{Volume}: 37
{Issue}: 4
{Year}: 2024 Jul
{Factor}: 2.162
{DOI}: 10.1111/jar.13265
{Abstract}: <B>BACKGROUND: </B>In people with intellectual disabilities and/or autism spectrum disorder, oral midazolam (OM) is very effective as premedication for facilitating medical treatment. In this retrospective study, we investigated the optimal dosage of OM for premedication.<BR><B>METHODS: </B>Patients with intellectual disability and/or autism spectrum disorder who were given OM as a premedication were selected from anaesthesia records. The primary outcome variable was the dose of OM (mg/kg) required to produce an adequate sedation.<BR><B>RESULTS: </B>The mean OM dose required was 0.32 ± 0.10 mg/kg. The required OM dose decreased significantly as age and weight increased, and age and weight were also shown to be significantly associated with the dose of OM in the multivariate linear regression analysis.<BR><B>CONCLUSIONS: </B>The dosage of OM to achieve adequate sedation should decrease as the patient ages. Furthermore, adequate sedation can be achieved with even lower doses of OM in obese people.